101 related articles for article (PubMed ID: 10340908)
1. Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization.
Rabbani F; Richon VM; Orlow I; Lu ML; Drobnjak M; Dudas M; Charytonowicz E; Dalbagni G; Cordon-Cardo C
J Natl Cancer Inst; 1999 May; 91(10):874-81. PubMed ID: 10340908
[TBL] [Abstract][Full Text] [Related]
2. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.
Møller MB; Kania PW; Ino Y; Gerdes AM; Nielsen O; Louis DN; Skjødt K; Pedersen NT
Leukemia; 2000 May; 14(5):898-904. PubMed ID: 10803523
[TBL] [Abstract][Full Text] [Related]
3. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
[TBL] [Abstract][Full Text] [Related]
4. Failure to detect mutations in the retinoblastoma protein-binding domain of the transcription factor E2F-1 in human cancers.
Nakamura T; Monden Y; Kawashima K; Naruke T; Nishimura S
Jpn J Cancer Res; 1996 Dec; 87(12):1204-9. PubMed ID: 9045954
[TBL] [Abstract][Full Text] [Related]
5. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
6. E2F-1: a proliferative marker of breast neoplasia.
Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas.
Gorgoulis VG; Zacharatos P; Mariatos G; Kotsinas A; Bouda M; Kletsas D; Asimacopoulos PJ; Agnantis N; Kittas C; Papavassiliou AG
J Pathol; 2002 Oct; 198(2):142-56. PubMed ID: 12237873
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of retinoblastoma and E2F family proteins during corneal development.
Francesconi CM; Hutcheon AE; Chung EH; Dalbone AC; Joyce NC; Zieske JD
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1054-62. PubMed ID: 10752941
[TBL] [Abstract][Full Text] [Related]
9. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
Ahmad N; Gupta S; Mukhtar H
Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
11. pRb and p107 regulate E2F activity during lens fiber cell differentiation.
Rampalli AM; Gao CY; Chauthaiwale VM; Zelenka PS
Oncogene; 1998 Jan; 16(3):399-408. PubMed ID: 9467965
[TBL] [Abstract][Full Text] [Related]
12. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
[TBL] [Abstract][Full Text] [Related]
13. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a chicken homolog of the E2F-1 transcription factor.
Pasteau S; Loiseau L; Arnaud L; Trembleau A; Brun G
Oncogene; 1995 Oct; 11(8):1475-86. PubMed ID: 7478572
[TBL] [Abstract][Full Text] [Related]
16. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines.
Zhang SY; Liu SC; Johnson DG; Klein-Szanto AJ
Cancer Res; 2000 Nov; 60(21):5972-6. PubMed ID: 11085515
[TBL] [Abstract][Full Text] [Related]
17. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.
Yamasaki L; Bronson R; Williams BO; Dyson NJ; Harlow E; Jacks T
Nat Genet; 1998 Apr; 18(4):360-4. PubMed ID: 9537419
[TBL] [Abstract][Full Text] [Related]
18. Allelic deletions of cell growth regulators during progression of bladder cancer.
Primdahl H; von der Maase H; Christensen M; Wolf H; Orntoft TF
Cancer Res; 2000 Dec; 60(23):6623-9. PubMed ID: 11118045
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional matrix suppresses E2F-controlled gene expression in glomerular mesangial cells.
Tsuboi N; Yoshida H; Kawamura T; Furukawa Y; Hosoya T; Yamada H
Kidney Int; 2000 Apr; 57(4):1581-9. PubMed ID: 10760093
[TBL] [Abstract][Full Text] [Related]
20. The gene expression index c-myc x E2F-1/p21 is highly predictive of malignant phenotype in human bronchial epithelial cells.
DeMuth JP; Jackson CM; Weaver DA; Crawford EL; Durzinsky DS; Durham SJ; Zaher A; Phillips ER; Khuder SA; Willey JC
Am J Respir Cell Mol Biol; 1998 Jul; 19(1):18-24. PubMed ID: 9651176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]